Plexxikon, a member of the Daiichi Sankyo Group, is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of competitively differentiated clinical and preclinical stage programs in a number of therapeutic areas and disease indications. Plexxikon’s platform enables the design of highly selective and targeted medicines, supporting the company’s broader strategy to develop personalized medicines.

Biotechnology

Plexxikon

Plexxikon's headquarters in South San Francisco, CA, United States

Plexxikon's Leadership Team includes Athanasios Tsiatis and 6 others.

��

People (1)

Jobs (0)

Other teams

��������

People (1)

Jobs (0)

Other teams

��